← Back to Clinical Trials
Recruiting NCT04614922

NCT04614922 Acceptance and Commitment Therapy-based Rehabilitation of Post-concussion Symptoms

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04614922
Status Recruiting
Phase
Sponsor St. Olavs Hospital
Condition Post-Concussion Syndrome
Study Type INTERVENTIONAL
Enrollment 48 participants
Start Date 2020-10-29
Primary Completion 2026-04

Trial Parameters

Condition Post-Concussion Syndrome
Sponsor St. Olavs Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 48
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2020-10-29
Completion 2026-04
Interventions
Acceptance and Commitment Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The investigators aim to evaluate effects of an outpatient rehabilitation program based on Acceptance and Commitment Therapy compared to usual care on function in patients with post-concussion syndrome (PCS) and post-traumatic headache (PTH). This study builds on the investigators' previous observational studies and treatment studies in this patient group.

Eligibility Criteria

Inclusion Criteria: * Having sustained a minimal HI or MTBI * PCS/ PTH had evolved within 1 week after the head trauma. * At least one post-concussion symptoms of at least moderate degree, that affects daily life. * \> 6 months post-injury. * First line treatment has been tried, e.g. psychoeducation, increase of physical activity and pharmacological treatments for headache Exclusion Criteria: * More than 5 years since last injury. * Symptoms are better explained by other conditions. * Severe communication problems, typically due to poor knowledge of Norwegian. * Severe psychiatric, neurological, somatic or substance abuse disorders that will make it problematic to function in a group and/or will complicate follow-up and outcome assessment.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology